<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>ARTICOLE ȘTIINȚIFICE</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/8218" rel="alternate"/>
<subtitle/>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/8218</id>
<updated>2026-07-08T08:59:35Z</updated>
<dc:date>2026-07-08T08:59:35Z</dc:date>
<entry>
<title>Metagenomics sequencing in infection diagnosis: clinical applications</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/33411" rel="alternate"/>
<author>
<name>Burlac, Veronica</name>
</author>
<author>
<name>Burduniuc, Olga</name>
</author>
<author>
<name>Colac, Svetlana</name>
</author>
<author>
<name>Iaconi, Oana-Simina</name>
</author>
<author>
<name>Bucov, Victoria</name>
</author>
<author>
<name>Lupu, Marina</name>
</author>
<author>
<name>Iliev, A.-M.</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33411</id>
<updated>2026-06-26T13:09:35Z</updated>
<published>2025-01-01T00:00:00Z</published>
<summary type="text">Metagenomics sequencing in infection diagnosis: clinical applications
Burlac, Veronica; Burduniuc, Olga; Colac, Svetlana; Iaconi, Oana-Simina; Bucov, Victoria; Lupu, Marina; Iliev, A.-M.
By  performing  a  literature  review,  to  identify  categories  of  patients  in  whom  metagenomics  sequencing  has  demonstrated  potential  clinical  relevance  in  the  diagnosis  of  infections, highlighting the practical applications, benefits and limitations of this method in the context of different clinical scenarios for further adaptation of clinical and laboratory diagnostic protocols.  The  study  is  descriptive  and  analytical.  A  literature  review  was  conducted,  using  literature  from  open  access  databases.  English  language  papers  relevant  to  the  proposed  research topic published in the last 5 years were selected according to the inclusion criteria.Metagenomics  sequencing  (mNGS)  is  an  innovative  technology  that  has  revolutionized  traditional  clinical  diagnostics  on  multiple  levels.  It  can  be  used  for  the  simultaneous  identification  of  multiple  pathogens  such  as  bacteria,  viruses,  fungi  and  parasites  in  clinical  samples. The application of metagenomics would bring considerable benefits even in cases of rare  infections  with  unknown  etiology  or  pathogens  that  are  difficult  to  culture.  This  study  demonstrates  how  this  new  technology  can  be  used  for  meaningful  clinical  diagnostics  in  microbiology. Patients with lower respiratory tract infections represent a category of patients for  whom  the  use  of  mNGS  brings  several  benefits,  this  technology  has  an  overall  higher  sensitivity  for  pathogen  detection  compared  to  the  culture  method  and  is  a  necessary  complement to conventional microbiologic tests. Sepsis is a major public health challenge and the  use  of  mNGS  for  this  category  of  patients  can  shorten  the  total  hospitalization  time  and  reduce mortality. Metagenomics sequencing technology is also useful for patients with central nervous system infections, the use of mNSG for those patients has a higher detection rate but the highest diagnostic yield is observed when combining mNGS with conventional methods. Metagenomics  offers  significant  benefits  in  the  detection  of  pathogens  also  in  patients  with  deep cervical space abscesses, with a superior detection rate and sensitivity, allowing early initiation  of  antimicrobial  therapy,  improved  prognosis  and  reduced  consumption  of  medical  resources. Metagenomics provides a complete, rapid and accurate identification of pathogens, significantly improving treatment, mainly when traditional methods are insufficient. Based on the studies presented in this article we can conclude that the application of metagenomics for patients with lower respiratory tract infections, sepsis, central nervous system infections and cervical  deep  space  infections  has  a  very  high  potential  to  reduce  morbidity,  mortality  and  health care costs.
</summary>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Genomic surveillance of wastewater for SARS-CoV-2 detection in the Republic of Moldova</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/33410" rel="alternate"/>
<author>
<name>Colac, Svetlana</name>
</author>
<author>
<name>Sîtnic, Victor</name>
</author>
<author>
<name>Burduniuc, Olga</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33410</id>
<updated>2026-06-26T11:19:39Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Genomic surveillance of wastewater for SARS-CoV-2 detection in the Republic of Moldova
Colac, Svetlana; Sîtnic, Victor; Burduniuc, Olga
This research study explored the diversity and prevalence of SARS-CoV-2 genetic lineages in wastewater&#13;
samples collected from the Chişinău wastewater treatment plant in the Republic of Moldova between September&#13;
and November 2024. A total of 23 samples were analysed using Illumina sequencing technology. Although&#13;
the overall quality of the sequencing data was suboptimal due to limited genomic coverage, the analysis&#13;
identified 32 genetic lineages based on the Pango Lineages classification. The most common variants detected&#13;
included B.1.177.66, B.1.1.243, and B.1.160.32. The study emphasises the importance of optimising the RNA&#13;
extraction process from wastewater to improve genome coverage and data accuracy. These findings provide&#13;
a foundation for future investigations involving sequencing genetic material obtained from environmental&#13;
samples, suggesting the applicability of wastewater surveillance to other types of pathogens or assessing the&#13;
resistome through metagenomic technology.; În cadrul prezentului studiu a fost evaluată diversitatea și abundența liniilor genetice ale virusului SARSCoV-2 în probe de ape uzate colectate la stația de epurare din Chișinău, Republica Moldova în perioada&#13;
septembrie - noiembrie 2024. Au fost analizate 23 probe de ape reziduale utilizând secvențierea prin&#13;
tehnologia Illumina. Deși calitatea generală a datelor de secvențiere a fost suboptimală, acoperirea genomică&#13;
fiind redusă, studiul a permis identificarea a 32 linii genetice conform clasificării Pango Lineages. Printre&#13;
cele mai abundente variante s-au numărat B.1.177.66, B.1.1.243 și B.1.160.32. În scopul îmbunătățirii acoperirii&#13;
genomice și acurateții rezultatelor, în lucrare este subliniată importanța optimizării etapei de extracție a ARNului din ape uzate. Studiul oferă premise pentru viitoare investigații privind secvențierea materialului genetic&#13;
obținut din probe de mediu, sugerând astfel aplicabilitatea monitorizării apelor uzate la alte tipuri de patogeni&#13;
sau la evaluarea rezistomului prin tehnnologia metagenomică.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Genetic significance and tracking of circulating SARS-CoV-2 variants in the Republic of  Moldova</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/33409" rel="alternate"/>
<author>
<name>Colac, Svetlana</name>
</author>
<author>
<name>Burduniuc, Olga</name>
</author>
<author>
<name>Apostol, Mariana</name>
</author>
<author>
<name>Druc, Alina</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/33409</id>
<updated>2026-06-26T10:50:31Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Genetic significance and tracking of circulating SARS-CoV-2 variants in the Republic of  Moldova
Colac, Svetlana; Burduniuc, Olga; Apostol, Mariana; Druc, Alina
Tracking the circulating variants of the SARS-CoV-2 virus and identifying new genetic variations provide&#13;
a high-resolution perspective with many advanced applications, ranging from developing diagnostic tests and&#13;
vaccines to real-time data for public health measures. This study aimed to investigate and assess the genetic&#13;
variants of SARS-CoV-2 circulating in the Republic of Moldova to improve COVID-19 response strategies.&#13;
A retrospective descriptive study was carried out in the National Public Health Agency virology laboratory.&#13;
The study analysed 417 biological samples collected from patients infected with COVID-19, with SARS-CoV-2&#13;
presence confirmed by molecular biology techniques (Reverse transcription polymerase chain reaction (RTPCR)). Viral fragment sequencing was performed via the Ion Torrent Genexus sequencer, Pangolin, and&#13;
GISAID (Global Initiative on Sharing All Influenza Data) software. The Omicron variant underwent multiple&#13;
genetic changes throughout 2022. Thus, these changes were divided into four distinct periods of SARS-CoV-2&#13;
genome evolution. The first period (January–March) was characterized by the predominance of BA.1* and its&#13;
subvariants; the second period (March–June) by the predominance of the BA.2* sublineage and its subvariants;&#13;
the third period (June–October) by the predominance of BA.4*/BA.5* and their subvariants; and, finally, in&#13;
the fourth-period various sublineages, including BQ.1*, BN.1*, CC.1*, and XBB.1.5, became predominant. In&#13;
conclusion, the implementation of advanced SARS-CoV-2 genome sequencing technologies in the Republic&#13;
of Moldova has proven the importance of detecting novel viral mutations and their impact on the epidemic&#13;
progression of the COVID-19 infection.; Monitorizarea variantelor circulante a virusului SARS-CoV-2 și detectarea apariției noilor variante&#13;
genetice permite obținerea unei imagini de înaltă rezoluție, cu multiple aplicații avansate, de la dezvoltarea&#13;
testelor de diagnostic și vaccinuri, până la informarea în timp real, asupra măsurilor de sănătate publică.&#13;
Scopul studiului a fost cercetare și monitorizarea variantelor genetice ale virusului SARS-CoV-2 circulante&#13;
în Republica Moldova în vederea perfecționării măsurilor de răspuns la COVID-19. A fost efectuat un&#13;
studiu descriptiv retrospectiv în baza datelor laboratorului virusologic din cadrul Agenției Naționale pentru&#13;
Sănătate Publică (Republica Moldova). Pentru studiu dat au fost analizate 417 probe biologice colectate de&#13;
la pacienți cu infecția COVID-19, prezența virusului SARS-CoV-2 a fost confirmat prin tehnici de biologie&#13;
molecură (RT-PCR). Secvențierea fragmentelor a fost efectuată cu secvențiatorul Ion Torrent Genexus și&#13;
utilizarea programelor Pangolin și GISAID (Inițiativa globală privind partajarea tuturor datelor despre gripă).&#13;
Varianta Omicron a suferit multe schimbări genetice pe tot parcursul anului 2022. Astfel, se poate distinge&#13;
patru perioade de importanță semnificativă a schimbării genomului virusului SARS-CoV-2: prima perioada –&#13;
ianuarie – martie predominarea BA.1* cu descendenții săi, a doua perioada – martie – iunie cu predominarea&#13;
subliniei BA.2* cu descendenții, iar a treia perioada lunile iunie – octombrie predominarea BA.4*/ BA.5* cu&#13;
descendenții și prin urmare a patra perioada - predominarea diverselor sublinii - BQ.1*, BN.1*, CC.1*, XBB.1.5.&#13;
În concluzie, datorită implementării în Republica Moldova a noilor tehnologii privind secvențierea genomului&#13;
virusului SARS-CoV-2 s-a demonstrat importanța cunoașterii procesului de apariție a mutațiilor noi de virus&#13;
și influența acestora asupra procesului epidemic al infecției COVID-19.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>INFLUENȚA UNOR COMPUȘI CHIMICI NOI ASUPRA PROCESELOR ENZIMATICE LA ESCHERICHIA COLI ȘI STAPHYLOCOCCUS AUREUS</title>
<link href="http://repository.usmf.md:80/xmlui/handle/20.500.12710/8331" rel="alternate"/>
<author>
<name>Zariciuc, Elena</name>
</author>
<id>http://repository.usmf.md:80/xmlui/handle/20.500.12710/8331</id>
<updated>2020-03-30T10:32:03Z</updated>
<published>2018-01-01T00:00:00Z</published>
<summary type="text">INFLUENȚA UNOR COMPUȘI CHIMICI NOI ASUPRA PROCESELOR ENZIMATICE LA ESCHERICHIA COLI ȘI STAPHYLOCOCCUS AUREUS
Zariciuc, Elena
În articol sunt prezentate rezultatele testării in vitro a acțiunii unor compuși noi asupra&#13;
activității proteazelor extracelulare și enzimelor antioxidante catalaza și superoxid&#13;
dismutaza extra- și intracelulare la Staphylococcus aureus ATCC®25922™, precum și a&#13;
enzimelor antioxidante la Escherichia coli ATCC®25923™.&#13;
Concentrațiile minime de inhibiție ale enotaninei solubile și compușilor chimici&#13;
noi, care conțin segmentul tiosemicarbazonic se manifestă ca inhibitori puternici ai&#13;
activității factorilor de patogenitate intra- și extracelulari la ambele tulpini studiate.&#13;
Concentrațiile mai joase decât cele minime de inhibiție pot induce atât sporirea, cât și&#13;
scăderea activității enzimatice la Escherichia coli ATCC®25923™ și Staphylococcus&#13;
aureus ATCC®25922™. Cel mai eficient inhibitor al activității enzimatice la acele&#13;
două tulpini dintre cei studiați este cloro-{N-(3,4-dimetilfenil)-2-[1-(2-hidroxifenil)&#13;
etiliden]-hidrazincarbotio -amido(1-)}nichelul, care în concentrație de 0,4 µg/ml elimină&#13;
complet activitatea catalazei extracelulare și o inhibă cu peste 70% pe cea a catalazei&#13;
intracelulare.
Universitatea de Stat de Medicină și Farmacie ”N.Testemițanu”
</summary>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</entry>
</feed>
